{
    "nctId": "NCT00919399",
    "briefTitle": "Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant",
    "officialTitle": "Phase II Study Evaluating the Effectiveness of the Exemestane (Aromasin) With Tamoxifen on the Rate of Clinical Response Menopausal in Patients With Locally Advanced Breast Tumors",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 15,
    "primaryOutcomeMeasure": "Evaluate the objective response rate (complete response and partial response)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer histologically proven by a 14 G or 16 G micro-biopsy to have confirmation of the diagnosis, evaluation histology prognosis grade, hormone receptors and to obtain a sample for the study of biological factors.\n* Menopausal patients as defined as follows:\n\n  * Natural menopause \\>= 1 year, or\n  * Surgical ovariectomy.\n* T unilateral tumor\\> 3 cm, N 1-2, M0 or M +, non-inflammatory.\n* Hormone receptor positive. RE positive or PR positive with histochemical technique (+ 10% of cells express the receptor)\n* No previous treatment of the disease by chemotherapy, hormone therapy, surgery or radiotherapy. Discontinuation of replacement therapy of menopause for at least 1 month\n* Age\\>= 60 years\n* Evaluable disease\n* Performance Status \\<= 2\n* Biological function using the following criteria:\n\n  * neutrophils \\>= 2.10E9 / l,\n  * Platelets\\> = 100.10E9 / l,\n  * Hemoglobin\\> = 10 g / dl,\n  * Creatinine \\<= 1.5 x upper normal,\n  * Total bilirubin \\<= 1.25 x the upper normal\n  * Transaminases (AST and ALT) \\<= 1.5 x upper normal,\n  * Alkaline phosphatase \\<= 2.5 x upper normal.\n* Cardiac Function: electrocardiogram (ECG) normal.\n* Signed written consent before any procedure related to the study.\n\nExclusion Criteria:\n\n* Men\n* Non Menopausal Patients\n* Patients with hormone receptor negative: PR- and RE -\n* Contra-indication to anti-estrogens (risk thrombi arteria)\n* Tumor \\<3 cm operable\n* Tumor inflammatory T4d (PEV 2 or 3).\n* Extensive hepatic lesions (\\> 1 / 3 of liver volume)\n* Uncontrolled cardiac disease such as angina, congestive heart failure, or arrhythmia requiring medical treatment or history of myocardial infarction within 3 months before.\n* History of cancer except skin cancer and basal cell cancer in situ of the cervix (a contralateral breast cancer had been no systemic treatment will be admitted).\n* Chronic diseases (somatic or psychiatric) in poor prognosis.\n* Patients who for reasons of family, social, geographical or psychological can not be followed properly.\n* Patients under law protection",
    "sex": "FEMALE",
    "minimumAge": "60 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}